• Home
  • Company
    • About Us
    • Team
    • Work With Us / FCOI
  • Products
  • Diseases
  • News
  • Contact Us
Close
  • Home
  • Company
    • About Us
    • Team
    • Work With Us / FCOI
  • Products
  • Diseases
  • News
  • Contact Us
HomeNews

CrossLife Tech’s IsoTARA COVID-19 Colorimetric Assay has been developed and submitted for EUA approval

June 4, 2020 1125
CrossLife Tech’s IsoTARA COVID-19 Colorimetric Assay  has been developed and submitted for EUA approval

June 2020 | In response to the global outbreak of COVID-19, CrossLife Technologies has developed the IsoTARATM COVID-19 Colorimetric Assay to perform near point-of-care where sample extraction is not necessary. The IsoTARA amplification processes...

Read more

CrossLife Tech’s Molecular Test for the Novel Coronavirus, CLT™ SARS-CoV-2 qRT-PCR, Has Developed.

June 1, 2020 915
CrossLife Tech’s Molecular Test  for the Novel Coronavirus,  CLT™ SARS-CoV-2 qRT-PCR, Has Developed.

June 2020 | In response to the global outbreak of the novel coronavirus disease (COVID-19), CrossLife Technologies has developed a real-time RT-PCR test, CLT™ SARS-CoV-2 qRT-PCR Assay, intended for the qualitative detection of nucleic acid...

Read more

CrossLife Awarded NIH SBIR II Grant for HIV Point-of-Care Diagnostic

October 27, 2018 4598
CrossLife Awarded NIH SBIR II Grant for HIV Point-of-Care Diagnostic

August 2018 | CrossLife has recently been awarded a Phase II Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Point of Care Detection of HIV virus. Point-of-Care Rapid RNA test for...

Read more

Serve on Special Emphasis Review Panel

March 3, 2017 3652
Serve on Special Emphasis Review Panel

March 2017 | CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay Development...

Read more

CrossLife on the News for NCATS Feature Story

February 3, 2017 5587
CrossLife on the News for NCATS Feature Story

CrossLife was on an NCATS feature story about SBIR grantees and NIH I-Corps training. https://ncats.nih.gov/pubs/features/sbir-i-corps   NIH I-Corps Training Helps NCATS-Supported Companies Find Their Way Learning what customers want I-Corps...

Read more

CrossLife Awarded NIH SBIR Grant for Zika Point-of-Care Diagnostic

January 13, 2017 2807
CrossLife Awarded NIH SBIR Grant for Zika Point-of-Care Diagnostic

January 2017 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Point of Care Detection of Zika virus.

Read more

Serve on Two Special Emphasis Review Panels

October 24, 2016 1922
Serve on Two Special Emphasis Review Panels

October 2016 | CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on two Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay...

Read more

CrossLife Awarded NIH SBIR Grant for Chikungunya Point-of-Care Diagnostic

July 10, 2016 1699
CrossLife Awarded NIH SBIR Grant for Chikungunya Point-of-Care Diagnostic

July 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for A Rapid Paper Strip Nucleic Acid Test for the Detection of Chikungunya at the Point of Care  ...

Read more

CrossLife Awarded NIH SBIR Grant for HIV Point-of-Care Diagnostic

July 10, 2016 1614
CrossLife Awarded NIH SBIR Grant for HIV Point-of-Care Diagnostic

July 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NIAID for Point-of-Care Rapid RNA test for HIV  ...

Read more

CrossLife successfully finished the NIH I-Corps entrepreneur immersion program

June 15, 2016 1408
CrossLife successfully finished the NIH I-Corps entrepreneur immersion program

June 2016 | We have successfully finished the NIH I-Corps entrepreneur immersion program (March 2016- May 2016). We have assembled an I-Corp team composed of an experienced industry expert who is a Key Opinion Leader in the diagnostics industry...

Read more

CrossLife Awarded NIH SBIR Grant for Influenza Virus Point-of-Care Diagnostic

May 15, 2016 1473
CrossLife Awarded NIH SBIR Grant for Influenza Virus Point-of-Care Diagnostic

May 2016 | CrossLife has recently been awarded a Phase 1 Small Business Innovative Research (SBIR) grant from NIH/NCATS for Point-of-Care Rapid RNA Diagnosis of Influenza Virus  ...

Read more

CrossLife selected for the NIH I-Corps entrepreneur immersion training program

March 15, 2016 1543
CrossLife selected for the NIH I-Corps entrepreneur immersion training program

March 2016 | NIH I-Corps | CrossLife has been selected for the highly competitive NIH I-Corps entrepreneur immersion training program. The goal of the program is to identify customers and markets for our point-of-care dengue diagnostic, and to...

Read more
12
Recent News
  • CrossLife Tech’s IsoTARA COVID-19 Colorimetric Assay has been developed and submitted for EUA approval
  • CrossLife Tech’s Molecular Test for the Novel Coronavirus, CLT™ SARS-CoV-2 qRT-PCR, Has Developed.
  • CrossLife Awarded NIH SBIR II Grant for HIV Point-of-Care Diagnostic
  • Serve on Special Emphasis Review Panel
  • CrossLife on the News for NCATS Feature Story
Archives
  • June 2020
  • October 2018
  • March 2017
  • February 2017
  • January 2017
  • October 2016
  • July 2016
  • June 2016
  • May 2016
  • March 2016
  • January 2016
  • December 2015
  • November 2015
  • June 2015
CrossLife Technologies © 2019. All Rights Reserved